MariMed
MariMed
MRMD
OTC
0.19
USD
58.33%
About
MariMed Inc. is a multi-state cannabis operator in the United States. The Company develops, owns, and manages seed to sale regulatory-compliant facilities for the cultivation, production, and dispensing of medicinal and adult-use cannabis. Its products include whole flowers, pre-rolled flowers, vape cartridges, concentrates, and edibles.
The Company’s Natures Heritage brand is a premium brand of cannabis flower and concentrates. Its Bettys Eddies brand is a cannabis supplement and nutrient-infused fruit chew that delivers better sleep, pain relief, stress relief, and more. Its Bubbys Baked brand is a soft and chewy baked goods and a hot chocolate mix.
Its Vibations brand is a cannabis-infused hydrating drink mix for discrete. The Company’s Kalm Fusion and K Fusion are chewable cannabis-infused mint tablets and InHouse is a brand of flower, vapes, and edibles. The Company’s Community Wellness & Compassionate Care Center, Inc. (Medleaf) is located in Prince George's County, Maryland..
Financials Amount (in millions)
Income statement
Balance sheet
Cash flow
Ratios
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 418.7K |
| Three Month Average Volume | 10.0M |
| High Low | |
| Fifty-Two Week High | 0.545 USD |
| Fifty-Two Week Low | 0.1379 USD |
| Fifty-Two Week High Date | 15 Sep 2023 |
| Fifty-Two Week Low Date | 05 Aug 2024 |
| Price and Volume | |
| Current Price | 0.1855 USD |
| Beta | 3 |
| Relative Price Change | |
| Four Week Relative Price Change | 15.44% |
| Thirteen Week Relative Price Change | -19.36% |
| Twenty-Six Week Relative Price Change | -38.65% |
| Fifty-Two Week Relative Price Change | -65.13% |
| Year-to-Date Relative Price Change | -43.00% |
| Price Change | |
| One Day Price Change | 3.63% |
| Thirteen Week Price Change | -13.69% |
| Twenty-Six Week Price Change | -32.55% |
| Five Day Price Change | -16.44% |
| Fifty-Two Week Price Change | -56.30% |
| Year-to-Date Price Change | -32.50% |
| Month-to-Date Price Change | 3.75% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 0.24142 USD |
| Book Value Per Share (Most Recent Quarter) | 0.23484 USD |
| Tangible Book Value Per Share (Last Fiscal Year) | 0.1641 USD |
| Tangible Book Value Per Share (Most Recent Quarter) | 0.13962 USD |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | 0.05345 USD |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 0.40891 USD |
| Revenue Per Share (Trailing Twelve Months) | 0.41509 USD |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | -99999.99 USD |
| Dividend Per Share (Trailing Twelve Months) | 0 USD |
| Dividend Per Share (5 Year) | -99999.99 USD |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | -0.04411 USD |
| Excluding Extraordinary Items (Trailing Twelve Months) | -0.04626 USD |
| Normalized (Last Fiscal Year) | -0.02421 USD |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | -0.04411 USD |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | -0.04626 USD |
| Including Extraordinary Items (Last Fiscal Year) | -0.04411 USD |
| Including Extraordinary Items (Trailing Twelve Months) | -0.04626 USD |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 0.03927 USD |
| Cash Per Share (Most Recent Quarter) | 0.0268 USD |
| Cash Flow Per Share (Last Fiscal Year) | -0.01879 USD |
| Cash Flow Per Share (Trailing Twelve Months) | -0.01711 USD |
| Free Cash Flow Per Share (Trailing Twelve Months) | -0.00744 USD |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | -7 |
| Cash Flow Revenue (Trailing Twelve Months) | -2 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | -6.29% |
| Pretax Margin (Last Fiscal Year) | -4.44% |
| Pretax Margin (5 Year) | -8.12% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 44.36% |
| Gross Margin (Trailing Twelve Months) | 43.27% |
| Gross Margin (5 Year) | 49.18% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | 2.66% |
| Operating Margin (Trailing Twelve Months) | -1.12% |
| Operating Margin (5 Year) | 4.81% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | -10.77% |
| Net Profit Margin (Trailing Twelve Months) | -11.11% |
| Net Profit Margin (5 Year) | -14.83% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | -3.85% |
| Tangible Book Value (5 Year) | -0.08% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | -99,999.99% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | 10.73% |
| Revenue Growth (3 Year) | 65.82% |
| Revenue Change (Trailing Twelve Months) | 10.97% |
| Revenue Per Share Growth | 46.01% |
| Revenue Growth (5 Year) | 42.93% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | 18.39% |
| Total Debt (5 Year) | 36.03% |
| Dividends | |
| Dividend Growth (3 Year) | -99,999.99% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | -64.15% |
| EPS Change (Trailing Twelve Months) | -407.99% |
| EPS Growth (3 Year) | -99,999.99% |
| EPS Growth (5 Year) | -99,999.99% |
| EBITDA | |
| EBITDA (5 Year) | -99,999.99% |
| EBITDA (5 Year Interim) | -99,999.99% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -99,999.99% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | 1 |
| Price to Tangible Book (Most Recent Quarter) | 1 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | -100,000 |
| Price to Free Cash Per Share (Trailing Twelve Months) | -100,000 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | 67.4M |
| Net Debt (Last Fiscal Year) | 55.0M |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 0 |
| Price to Sales (Trailing Twelve Months) | 0 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | -100,000 |
| PE Normalized (Last Fiscal Year) | -100,000 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | 288 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | 10 |
| PE Including Extraordinary Items (Trailing Twelve Months) | -100,000 |
| Dividends | |
| Dividend Yield (5 Year) | -99,999.99% |
| Dividend Yield | -99,999.99% |
| Current Dividend Yield | 0.00% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | 1 |
| Price to Book (Most Recent Quarter) | 1 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 75 |
| Long Term Debt to Equity (Most Recent Quarter) | 81 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | -99,999.99% |
| Payout Ratio (Trailing Twelve Months) | -99,999.99% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 1 |
| Quick Ratio (Most Recent Quarter) | 1 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | -100,000 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | -100,000 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 2 |
| Current Ratio (Most Recent Quarter) | 1 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | -12,846,000 |
| Free Cash Flow (Trailing Twelve Months) | -2,799,000 |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | 2 |
| Net Interest Coverage (Trailing Twelve Months) | 1 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 77 |
| Total Debt to Equity (Most Recent Quarter) | 87 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | -9.19% |
| Return on Assets (Trailing Twelve Months) | -8.72% |
| Return on Assets (5 Year) | -13.42% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | -24.59% |
| Return on Equity (Trailing Twelve Months) | -22.74% |
| Return on Equity (5 Year) | -41.55% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | -10.88% |
| Return on Investment (Trailing Twelve Months) | -10.47% |
| Return on Investment (5 Year) | -17.50% |